Approval · Notice of Compliance 38366 · 2026
MAR-FLECAINIDE: Notice of Compliance 38366
Issued September 25, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38366
- Date
- September 25, 2026
- Company
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to Product Monograph (to align with CRP approved PM)
- Canadian reference product
- FLECAINIDE (AA Pharma Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MAR-FLECAINIDE | Not yet assigned | — |
Medicinal ingredients
- FLECAINIDE ACETATE 50 MG per TAB
- FLECAINIDE ACETATE 100 MG per TAB